Biswas Smita MD - Woodhaven, New York 11421

Biswas Smita MD is categorized under Doctors in Woodhaven, NY .

Business Name: Biswas Smita MD
Contact Person: Smita Biswas
Address: 8387c Woodhaven Boulevard, Woodhaven, New York 11421
Phone Number: (718) 846-1313
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Avant Gard Medical Practice - Woodhaven, NY 11421
Short Robby F MD - Woodhaven, NY 11421
Vasa Chira G MD - Woodhaven, NY 11421
Colvin George L DO - Woodhaven, NY 11421
Amigo Nancy MD - Woodhaven, NY 11421
Idanan Lilia B MD - Woodhaven, NY 11421
Chan Amigo Nancy Lee MD - Woodhaven, NY 11421
Lodha Ajay K MD - Woodhaven, NY 11421
Medical Select Pc - Woodhaven, NY 11421
Richards Neil M MD - Woodhaven, NY 11421
Caguiat Juanito MD - Woodhaven, NY 11421
Mahadkar Mohan MD - Woodhaven, NY 11421
Avengruab Medical Group - Woodhaven, NY 11421
Nazarian H MD - Woodhaven, NY 11421
Muraca Glenn J DO - Woodhaven, NY 11421
Roy G Aiello Md - Woodhaven, NY 11421
Marciano Giovanni DO - Woodhaven, NY 11421
Pro Motion Physical Therapy - Woodhaven, NY 11421
Mandel & Amigo - Woodhaven, NY 11421
Gholomhossani Asshin MD - Woodhaven, NY 11421

The company Biswas Smita MD provides B2C services in the form of Doctors from its single location in New York. 1 to 4 employees work for Biswas Smita MD, and the business now earns $500.000 to $999.999 per annum.

Biswas Smita MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Biswas Smita MD, please call Smita Biswas with the phone number (718) 846-1313 or visit its single location at 8387c Woodhaven Boulevard in Woodhaven, New York 11421.

The location of the single location can also be found using the coordinates 40.69874,-73.85289. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.